ExploreWatchlistsPricing
  1. JP-listed companies
  2. Alfresa Holdings Corporation
  3. Financials
  4. Gross margin (%)

Alfresa Holdings Corporation (2784)

Market cap
¥463.6B
P/E ratio
12.2x
Alfresa Holdings distributes prescription drugs, medical devices, and healthcare products to serve Japan's medical industry through specialized subsidiaries.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndGross margin (%) YoY (%)
Mar 31, 20257.2+0.07%
Mar 31, 20247.2+1.33%
Mar 31, 20237.1-1.73%
Mar 31, 20227.3+7.58%
Mar 31, 20216.7-12.17%
Mar 31, 20207.7+0.66%
Mar 31, 20197.6+2.52%
Mar 31, 20187.4+4.00%
Mar 31, 20177.1-6.61%
Mar 31, 20167.7+11.79%
Mar 31, 20156.8

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat